Medical Treatment for Hepatocellular Carcinoma in Japan

  • Kawano Youichi
    Department of Surgery, Nippon Medical School Chiba Hokusoh Hospital
  • Kaneya Yohei
    Department of Surgery, Nippon Medical School Chiba Hokusoh Hospital
  • Aoki Yuto
    Department of Surgery, Nippon Medical School Chiba Hokusoh Hospital
  • Yoshioka Masato
    Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School Hospital
  • Matsushita Akira
    Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School Hospital
  • Shimizu Tetsuya
    Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School Hospital
  • Ueda Junji
    Department of Surgery, Nippon Medical School Chiba Hokusoh Hospital
  • Takata Hideyuki
    Department of Digestive Surgery, Nippon Medical School Musashikosugi Hospital
  • Taniai Nobuhiko
    Department of Digestive Surgery, Nippon Medical School Musashikosugi Hospital
  • Kanda Tomohiro
    Department of Surgery, Nippon Medical School Tama Nagayama Hospilal
  • Hirakata Atsushi
    Department of Surgery, Nippon Medical School Tama Nagayama Hospilal
  • Suzuki Hideyuki
    Department of Surgery, Nippon Medical School Chiba Hokusoh Hospital
  • Yoshida Hiroshi
    Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School Hospital

この論文をさがす

抄録

<p>Liver cancer, including hepatocellular carcinoma (HCC), is the fifth most common cause of cancer deaths in Japan. The main treatment options for HCC are surgical resection, liver transplantation, radiofrequency ablation (RFA), transarterial chemoembolization (TACE), and systemic chemotherapy. Here, recent medical treatments for HCC, including surgery, percutaneous ablation, transcatheter arterial chemoembolization/transcatheter arterial embolization, and drug therapy, are reviewed with a focus on Japan.</p>

収録刊行物

  • 日医大誌

    日医大誌 89 (2), 154-160, 2022-04-25

    日本医科大学医学会

被引用文献 (1)*注記

もっと見る

参考文献 (45)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ